Ciitizen Secures $17 Million Series A Funding to Accelerate Development of Its Digital Health Records Platform

VCBeat (WeChat Official Account: vcbeat) has learned that on January 16, Ciitizen, a consumer health technology company based in California, USA, announced the completion of a $17 million Series A financing round. The round was led by Andreessen Horowitz, with participation from Section 32 and Verily. Ciitizen will use the proceeds to accelerate platform development and expand its commercial operations. Meanwhile, Vijay Pande, General Partner at Andreessen Horowitz, will join Ciitizen’s Board of Directors; Michael Pellini, Managing Partner at Section 32, and Andy Harrison, Head of Business Development at Verily, will join the board as observers.

Ciitizen, founded in 2017, is a consumer health technology company with a mission to provide patients with a transparent platform for controlling their health data in a seamless manner. Ciitizen is committed to building a leading platform that helps patients digitally collect, organize, and share their medical records.

In July 2018, Ciitizen secured a $3 million seed funding round led by Andreessen Horowitz; this Series A financing followed its previous funding round.

“Ciitizen has a unique understanding of the challenges faced by cancer patients, including the various issues patients encounter in managing their medical records within our current healthcare system,” said Vijay Pande. “Leveraging their profound insights, the Ciitizen team has developed advanced technologies and tools to address these issues, empowering patients and ultimately saving lives.”

“Continued support from Andreessen Horowitz reaffirms the rapid progress we have made and further validates our potential to make a significant impact on healthcare globally. Meanwhile, the addition of Section 32 and Verily further enhances our ability to transform how patients engage with their health data,” said Anil Sethi, CEO and Founder of Ciitizen.

As the Ciitizen platform continues to evolve, the company is preparing to launch products that will have a direct impact on healthcare.

“We are actively recruiting staff and supporting product launches through collaborations with other healthcare institutions, all of which rely on accessing patients’ health data,” said Premal Shah, Chief Operating Officer and Co-Founder of Ciitizen. “We aim to deliver the greatest direct benefit to patients by leveraging their personal healthcare data.”

In addition to launching its medical records platform within less than a year of its founding, Ciitizen also initiated a weekly blog, The Ci of Citizens, which features insights from healthcare thought leaders on how to overcome some of the most pressing challenges in healthcare.

“We will always be committed to securing the greatest possible benefit for patients and will continue to collaborate with thought leaders in the medical field,” said Anil Sethi.

Andreessen Horowitz, founded in 2009 by Marc Andreessen and Ben Horowitz, is a venture capital firm based in Silicon Valley, California. Andreessen Horowitz supports entrepreneurs in growing their businesses through technology and invests in technology-driven companies.

Section 32 is a California-based venture capital fund founded by Bill Maris, the founder of Google Ventures. Section 32 primarily invests in technology, biotechnology, healthcare, and life sciences startups.

Verily (formerly Google Life Sciences) is a research institution of Alphabet Inc. dedicated to life sciences research. Verily focuses on leveraging technology to better understand health, as well as to prevent, detect, and manage diseases.